Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 15:381:e068911.
doi: 10.1136/bmj-2021-068911.

Use of real world data to improve drug coverage decisions in China

Wen Wang  1   2   3 , Jing Tan  1   2   3 , Jing Wu  4 , Shiyao Huang  1   2   3 , Yunxiang Huang  1   2   3 , Feng Xie  5 , Xin Sun  1   2   3
Affiliations

Use of real world data to improve drug coverage decisions in China

Wen Wang et al. BMJ. .

Abstract

Wen Wang and colleagues discuss the rationale and propose a framework for using real world evidence to support coverage decisions in Chinese setting

PubMed Disclaimer

Conflict of interest statement

Competing interests We have read and understood BMJ policy on declaration of interests and declare that the study was supported by the National Key R&D Program of China (Grant No 2017YFC1700406 and 2017YFC1700400), the National Natural Science Foundation of China (Grant No 82225049, 72104155), China Medical Broad (Grant No CMB 19-324), and 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (Grant No ZYYC08003). These funders had no role in the study design, collection, analysis, or interpretation of the data, writing the manuscript, or the decision to submit the paper for publication.

References

    1. Chinese State Council. 74 drugs to be added to national insurance list. 2021. http://english.www.gov.cn/statecouncil/ministries/202112/07/content_WS61...
    1. Technology Development Center of Chinese Pharmaceutical Association . Blue book on progress and achievement of medical insurance reform in China. CPA, 2021.
    1. Chinese State Council. Over 60 rare-disease drugs approved for Chinese market. 2021. https://english.www.gov.cn/statecouncil/ministries/202112/19/content_WS6...
    1. Tang Z, Guo J, Tang J, Ying X. Analysis on the current situation of listed innovative drugs in China from 2017 to 2020. World Clinical Drugs 2022;43:294-9.
    1. Zhou T, Sheng Y, Guan H. Cost-effectiveness of vedolizumab in the treatment of moderate-to-severe Crohn’s disease in China. Adv Ther 2021;38:4233-45. 10.1007/s12325-021-01806-7 - DOI - PMC - PubMed